CV and abstract Ravi Basavappa - B·Debate

RAVI BASAVAPPA
CV
PARTICIPANT OF:
GOOD PRACTICES FOR FOSTERING
TRANSFORMATIVE RESEARCH IN
HEALTH AND LIFE SCIENCES
May, 10 th -11 th , 2012, Barcelona
Ravi Basavappa, Ph.D.
Program director, National Institute of General Medical Sciences, NIH
Ravi Basavappa, Ph.D., is a program director in the Division of Cell Biology and
Biophysics. He administers grants in the areas of the biophysical properties of
proteins, viral attachment, assembly, fusion and budding; and structure-based design
of HIV therapeutics. Basavappa is involved in other NIGMS programs, including the
trans-NIH EUREKA initiative and the Protein Structure Initiative. In addition, he
serves as the Institute’s AIDS coordinator. Before joining NIGMS, Basavappa was an
associate professor in the department of biochemistry and biophysics at the University
of Rochester. He earned a B.S. in physics from Duke University and a Ph.D. in
biophysics from the University of Chicago. Basavappa conducted postdoctoral research
at Harvard Medical School. Dr. Basavappa is also responsible for the managemener of
the NIH Director's New Innovator Awards, NIH Director's Pioneer Awards, Director's
Transformative R01 (TR01) Award, NIH Director's Early Independence Awards,
Nanomedicine, Metabolomics (planning activity) and Single Cell Analysis (planning
activity).

RAVI BASAVAPPA
ABSTRACT
PARTICIPANT OF:
GOOD PRACTICES FOR FOSTERING
TRANSFORMATIVE RESEARCH IN
HEALTH AND LIFE SCIENCES
May, 10 th -11 th , 2012, Barcelona
“NIH High-Risk, High-Reward Research Programs”
The United States National Institutes of Health (NIH) is the steward of medical and
behavioral research for the nation. As such, it supports studies that seek fundamental
knowledge about living systems as well as studies that apply that knowledge to
improve the public health. Within this very broad mission of NIH, the High-Risk
High-Reward (HRHR) Program of the NIH Common Fund, housed within the NIH
Office of the Director, seeks specifically to solicit, identify, and support exceptionally
innovative researchers and research that may produce results of unusually broad
impact but perhaps would not be supported through conventional NIH mechanisms.
The four different initiatives (the Pioneer Awards, New Innovator Awards,
Transformative Research Awards, and Early Independence Awards) that comprise the
High-Risk High-Research program will be discussed. Topics will include special
features that set these apart from conventional NIH mechanisms, how these initiatives
have fared in attracting and promoting HRHR research, and lessons learned in
managing a HRHR program.